HILLSIDE, N.J., Sept. 7 /PRNewswire-FirstCall/ -- Integrated BioPharma, Inc. (Amex: INB - News) announced today, the closing of a new $15.0 million revolving credit facility with Amalgamated Bank on September 1, 2006. INB initially utilized $5.0 million of the line to refinance its $4.5 million note to the Bank of America and other miscellaneous debt and obligations including the costs associated with securing the facility.
